1st Quarter - Report — BELL HEROUX, LLC for SICKLE CELL DISEASE ASSOCIATION OF AMER… (2014)

Firm

BELL HEROUX, LLC

Client

SICKLE CELL DISEASE ASSOCIATION OF AMERICA, INC

Income

—

Expenses

—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Matters related to the FY 2013 budget and appopriations bills for programs within HRSA, CMS, NIH, and other agencies for the treatment and cure of Sickle Cell Disease.

Lobbyist	Covered position, as disclosed
STEPHAN DMITRI BELL	Leg. Dir., Rep. Earl Hilliard
JON PAUL HEROUX	Chief Counsel, US Merit Systems Protection Board

Contacted: Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE

Health Issues HCR

Issues related to reauthorization of the Sickle Cell Disease Treatment Act, the New Born Screening Program and other matters related to the treatement and research for the cure to Sickle Cell Disease

Lobbyist	Covered position, as disclosed
STEPHAN DMITRI BELL	Leg Director, Rep. Earl Hilliard
JON PAUL HEROUX	Chief Counsel, Merit Systems Protection Board

Contacted: Health Resources & Services Administration (HRSA); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.